Received Sep 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y015179 | — |
the patient did not experience any adverse issues or reactions from the administered vaccine; a TE for GARDASIL 9 that took place on 07/08/2025 as well as 08/20/2025 and was inadvertently administered on 08/25/2025.; This spontaneous report was received from a medical assistant and refers to a 10-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 08-JUL-2025, human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) lot #Y015179 underwent temperature excursion (47.3 F for 50 minutes 20 seconds). On 20-AUG-2025, the vaccine underwent another temperature excursion (46.4 F for 25 minutes 50 seconds). On 25-AUG-2025, the patient was inadvertently vaccinated with improperly stored human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) suspension for injection at a total dose of 0.5 mL, lot #Y015179, expiration date: 28-JAN-2027, administered for prophylaxis (route of administration and anatomical location were not reported) (Product storage error). The patient did not experience any adverse issues or reactions from the administered vaccine. This is one of several reports received from the same reporter.